drugset / Trial / NCT00645086

Comparative Study of 5 Days of M02-472 Clarithromycin Extended-Release Tablets to 7 Days of Clarithromycin Immediate-Release Tablets for the Treatment of Exacerbation of Chronic Bronchitis

NCT00645086

Phase 3 Completed 465 enrolled Abbott
RandomizedParallel-groupDouble-blindTreatment

Summary

To compare the efficacy of a 5-day course of clarithromycin extended-release tablets (2 x 500 mg QD) with that of a 7-day course of clarithromycin immediate-release tablets (1 x 500 mg BID) in the treatment of acute bacterial exacerbation of chronic bronchitis.

Timeline

Start
2002-12
Primary completion
2004-04
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clarithromycin Small molecule 500 mg
Comparator Clarithromycin Small molecule 1000 mg

Indications